Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 11Breast Neoplasms 11Obesity 8Motor Activity 7Malnutrition 6Lung Neoplasms 6Prostatic Neoplasms 5Overweight 5Colorectal Neoplasms 5Weight Loss 4Hypertension 4Stroke 3Stomach Neoplasms 3Pancreatic Neoplasms 3Heart Failure 3Diabetes Mellitus 3Cardiovascular Diseases 3Sarcopenia 2Polycystic Ovary Syndrome 2Osteoporosis 2Kidney Diseases 2Inflammation 2Heart Diseases 2Gastrointestinal Neoplasms 2Frailty 2Esophageal Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Cachexia 2Arthritis 2

Interventions

Gemcitabine 157Cisplatin 116pembrolizumab 80Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Cystectomy 40Docetaxel 38atezolizumab 33Magnetic Resonance Spectroscopy 31durvalumab 30Radiotherapy 29BCG Vaccine 26avelumab 24Specimen Handling 24Doxorubicin 23enfortumab vedotin 22Fluorouracil 20Cystoscopy 20Methotrexate 17Vinblastine 16Standard of Care 15Filgrastim 14Transurethral Resection of Bladder 13Sunitinib 13Ipilimumab 13vinflunine 125-aminolevulinic acid hexyl ester 12tremelimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urinary Bladder Neoplasms × Nutrition Assessment × Clear all
NCT06414317 2026-01-29

An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers

Roswell Park Cancer Institute

Phase NA Recruiting
160 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡